Next-generation sequencing analysis of miRNA expression in control and FSHD myogenesis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Colangelo, Veronica ^a   François, Stéphanie ^a   Solda, Giulia ^b   Picco, Raffaella ^c   Roma, Francesca ^b   Ginelli, Enrico ^b   Meneveri, Raffaella ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 1268; MICRORNA 1268B; MICRORNA 133A; MICRORNA 133B; MICRORNA 1908; MICRORNA 206; MICRORNA 4258; MICRORNA 4508; MICRORNA 4516; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; MUSCLE DEVELOPMENT; MYOTUBE; NEXT GENERATION SEQUENCING ANALYSIS; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION; CASE CONTROL STUDY; CELL LINE; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; MYOBLAST; PATHOLOGY; PROCEDURES; REPRODUCIBILITY;

CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOBLASTS; REPRODUCIBILITY OF RESULTS;

EID: 84907681333     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108411     Document Type: Article

References (55)

1. Padberg GW, Lunt PW, Koch M, Fardeau M (1992) Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord 1:231 -4
2. Tupler R, Gabellini D (2004) Molecular basis of facioscapulohumeral muscular dystrophy. Cell Mol Life Sci 61:557-66
3. Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, et al. (1992) Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nature Genetics 2:26-30
4. Yamanaka G, Goto K, Ishihara T, Oya Y, Miyajima T, et al. (2004) FSHD-like patients without 4q35 deletion. J Neurol Sci 219:89-93
5. Arashiro P, Eisenberg I, Kho AT, Cerqueira AM, Canovas M, et al. (2009) Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers. Proc Natl Acad Sci USA 106:6220-5
6. Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camaño P, et al. (2010) A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329:1650-3
7. Cabianca DS, Casa V, Bodega B, Xynos A, Ginelli E, et al. (2012) A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell 149:819-31
8. Scionti I, Greco F, Ricci G, Govi M, Arashiro P, et al. (2012) Large-scale population analysis challenges the current criteria for the molecular diagnosis of facioscapulohumeral muscular dystrophy. Am J Hum Genet 90:628:35
9. Cheli S, François S, Bodega B, Ferrari F, Tenedini E, et al. (2011) Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns. PLoS One 6(6)
10. Tsumagari K, Chang SC, Lacey M, Baribault C, Chittur SV, et al. (2011) Gene expression during normal and FSHD myogenesis. BMC Med Genomics 4:67
11. Rahimov F, King OD, Leung DG, Bibat GM, Emerson CP Jr, et al. (2012) Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. Proc Natl Acad Sci USA 109:16234-9
12. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, et al. (2007) Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA 104:17016-21
13. Ge Y, Chen J (2011) MicroRNAs in skeletal myogenesis. Cell Cycle 10:441-8
14. Snider L, Asawachaicharn A, Tyler AE, Geng LN, Petek LM, et al. (2009) RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: New candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum Mol Genet 18:2414-30
15. Bartel DP (2009) MicroRNAs: Target recognition and regulatory functions. Cell 136:215-33
16. Kloosterman WP, Plasterk RH (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11:441-50
17. Mendell JT (2005) MicroRNAs: Critical regulators of develompment, cellular physiology and malignancy. Cell Cycle 4:1179-84
18. Zhao Y, Samal E, Srivastava D (2005) Serum response factor regulates a muscle-specif microRNA that targets Hand2 during cardiogenes is. Nature 436:214-20
19. Chen JE, Mandel EM, Thomson JM, Wu Q, Callis TE, et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228 -33
20. Dmitriev P, Barat A, Polesskaya A, O'Connell MJ, Robert T, et al. (2013) Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes. BMC Genomics 14:265
21. Dmitriev P, Stankevicins L, Ansseau E, Petrov A, Barat A, et al. (2013) Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients. J Biol Chem 288:34989-5002
22. Witkos TM, Koscianska E, Krzyzosiak WJ (2011) Practical Aspects of microRNA Target Prediction. Current Molecular Medicine 11:93-109
23. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominandy act to decrease target mRNA levels. Nature 466:835-40
24. Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, et al. (2003) Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 12:2895-907
25. Osborne RJ, Welle S, Venance SL, Thornton CA, Tawil R (2007) Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology 68:569-77
26. Ryu S, Joshi N, McDonnell K, Woo J, Choi H, et al. (2011) Discovery of novel human breast cancer microRNAs from deep sequencing data by analysis of pri-microRNA secondary structures. PLoS One 6:el6403
27. Xu G, Wu J, Zhou L, Chen B, Sun Z, et al. (2010) Characterization of the small RNA transeriptomes of androgen dependent and independent prostate cancer cell line by deep sequencing. PLoS One 5:el5519
28. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401-14
29. Luo W, Nie Q, Zhang X (2013) MicroRNAs involved in skeletal muscle differentiation. J Genet Genomics 40:107-16
30. Ferreboeuf M, Mariot V, Bessières B, Vasiljevic A, Attié-Bitach T, et al. (2014) DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles. Hum Mol Genet 23:171-81
31. McCarthy JJ (2008) MicroRNA-206: The skeletal muscle-specific myomiR. Biochim Biophys Acta 1779:682-91
32. Townley-Tilson WH, Calks TE, Wang D (2010) MicroRNAs 1, 133, and 206: Critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol 42:1252-5
33. Callis TE, Deng Z, Chen JF, Wang DZ (2008) Muscling through the microRNA world. Experimental biology and medicine 233:131-138
34. Wu J, Ji X, Zhu L, Jiang Q, Wen Z, et al. (2013) Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells. Cancer Lett 329:155-63
35. Nohata N, Hanazawa T, Kinoshita T, Inamine A, Kikkawa N, et al. (2013) Tumor-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma. Br J Cancer 108:1648-58
36. Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:1290 -7
37. Dong S, Xiong W, Yuan J, Li J, Liu J, et al. (2013) MiRNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-kB expression. Mol Med Rep 8:407-12
38. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, et al. (2008) Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 18:610:21
39. Yang Q, Hua J, Wang L, Xu B, Zhang H, et al. (2013) MicroRNA and piRNA profiles in normal human testis detected by next generation sequencing. PLoS One 8:e66809
40. Schee K, Lorenz S, Worren MM, Günther CC, Holden M, et al. (2013) Deep sequencing the microRNA transcriptome in colorectal cancer. PLoS One 8:e66165
41. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF (2006) Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Nad Acad Sci USA 103:8721-6
42. Goljanek-Whysall K, Sweetman D, Münsterberg AE (2012) microRNAs in skeletal muscle differentiation and disease. Clin Sci (Lond) 123:611-25
43. Alexander MS, Casar JC, Motohashi N, Myers JA, Eisenberg I, et al. (2011) Regulation of DMD pathology by an ankyrin-encoded miRNA. Skelet Muscle 1:27.
44. Celegato B, Capitanio D, Pescatori M, Romualdi C, Pacchioni B, et al. (2006) Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics 6:5303-21
45. Broucqsault N, Morere J, Gaillard MC, Dumonceaux J, Torrents J, et al. (2013) Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy. Hum Mol Genet 22:4206-14
46. Ottaviani A, Schluth-Bolard C, Rival-Gervier S, Boussouar A, Rondier D, et al. (2009) Identification of a perinuclear positioning element in human subtelomeres that requires A-type lamins and CTCF. EMBO J 28:2428-36
47. Bodega B, Ramirez CD, Crasser F, Cheli S, Brunelli S, et al. (2009) Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol 7:41
48. Homma S, Chen JC, Rahimov F, Beermann ML, Hanger K, et al. (2012) A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family disease and cell function. Eur J Hum Genet 20:404-10
49. Brunelli S, Tagliafico E, De Angelis FC, Tonlorenzi R, Baesso S, et al. (2004) Msx2 and needin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells. Circ Res 94: 1571-8
50. Sanges R, Cordero F, Calogero RA (2007) oneChannelGUI: a graphical interface to Bioconductor tools, designed for life scientists who are not familiar with R language. Bioinformatics 23:3406-8
51. Cordero F, Beccuti M, Arigoni M, Donatelli S, Calogero RA (2012) Optimizing a massive parallel sequencing workflow for quantitative miRNA expression analysis. PLoS One 7:e31630
52. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787-798
53. da Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoe 4:44-57
54. da Huang W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1-13
55. Pisconti A, Brunelli S, Di Padova M, De Palma C, Deponti D, et al. (2006) Follistatin induction by nitric oxide through cyclic CMP: A tighdy regulated signaling pathway that controls myoblast fusion. J Cell Biol 172:233-44